NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
Agency
National Institutes of Health
Posted
Sep 24, 2026
Due Date
May 25, 2027
Description
<p style="margin-left:0in;">This Notice of Funding Opportunity (NOFO) solicits applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. The program supports the preparation of book-length manuscripts and other scholarly works of academic and/or public health importance to U.S. health professionals, scientists, public health professionals, and other relevant audiences. This NOFO is intended to support scholars in producing critical reviews, analytical syntheses, and other integrative scholarly works that organize, contextualize, and disseminate biomedical and health-related knowledge. Through support for rigorous and integrative scholarship, the G13 program seeks to foster works that deepen understanding of current biomedical and public health challenges and contribute enduring resources for research, education, clinical practice, and public health.</p>
AI Summary
Estimated Funding: 320,000 | Award Ceiling: 80,000 | Agency: National Institutes of Health
Details
- Notice ID
- 363939
- Solicitation Number
- PAR-28-027
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health